Gilboa Therapeutics is delighted to welcome Barry Labinger as CEO

Barry Labinger brings more than 30 years of experience in leadership roles in the biopharmaceutical industry, including both public and private companies. 

We look forward to a successful journey together!

Read more about Barry here

June 15, 2022